About us
How it all started.
Bernhard Paetzold and Marc Güell are the scientists behind S-Biomedic. In 2014, these two PhD-grads became fascinated with the applied health potential of the body’s microbiome. Inspired by gut microbiome transplantation, they set off to translate the concept of microbiome transplantation to the skin. Their goal was simple: “Restore the skin’s healthy balance”.
They were joined by business entrepreneur Veronika Oudova and S-Biomedic was born with the mission of transforming the paradigm of skin health care.
After years of intensive research, the team performed the first-ever skin microbiome transplantation. The process of transferring a healthy skin microbiome onto the skin of those suffering from chronic skin conditions (e.g. acne, eczema or psoriasis) proved to be a wild success.
Meet the S-Biomedic team
Veronika Oudova
Chief Executive Officer & Co-founder
Bernhard Päetzold
Chief Scientific Officer & Co-founder
Marc Guëll
Scientific Director & Co-founder
Wesley Carpentier
Chief Commercial Officer
Purpose
To encourage hope, provide fresh perspective, and support new opportunities for people who care.
Vision
We believe in the innate power of the skin and its microbiome — together, this is the new frontier in health, dermatology, and skincare.
Mission
To become the global leader in the pioneering and commercialization of microbiome dermatological skincare solutions.
Core values
Develop networks, relationships, and ultimately solutions to drive advances in dermatology and skincare.
Meet our Scientific Advisory Board
Prof. Gollnick is the key opinion leader in acne, non-melanoma skin cancer and general dermatology. He has over 400 peer-reviewed, 200 proceedings publications and 8000 citations in the dermatology field. He led and represented many scientific institutions within Europe.
He was a member of the Board of Directors of the European Academy of Dermatology and Venereology. He was the Secretary General and President of the European Dermatology Forum (EDF). He was also Founder and Chairman of German Acne Academy and Global Alliance Acne.
He was President of the German Society of Dermatology and a continuous board member. He was President of the Dermato-Venereology Section of the European Union of Medical Specialists. Currently, he is a Visiting Professor of Kaunas Medical University Lithuania. In addition, he acts as advisor for international consultant agencies. Finally, he is honorary member of several national societies worldwide and has received highest awards from International League of Dermatological Societies, European Dermatology Forum and German Society of Dermatology.
Prof. Dr. Harald Gollnick
Holger is an Associate Professor at the Department of Biomedicine, Health Faculty, Aarhus University in Denmark since 2011. His team works at the interface of microbial genomics, medical microbiology and host-bacterium/microbiome interactions. He completed his PhD thesis at the University of Göttingen, Germany, in 2003. He was a Postdoc at the Pasteur Institute, Paris, France, for 3 years, followed by a staff scientist position at the Max Planck Institute for Infection Biology, Berlin, Germany.
Prof. Holger Bruggemann
Dr Lieve Declercq is Innovation Consultant for Health and Beauty with 25+ years management experience. She is partnering with Belgian and international companies for technology validation, product development and market introduction, aimed at driving business growth.
Until end 2017, Dr Declercq was VP of Basic Science Research & Advanced Technologies at the Estée Lauder Companies, one of the world’s leading manufacturers of prestige cosmetic products (total net sales $13.68 billion in FY2018). She created strategies for technology innovation and product development with a global network of innovation partners. Her research was published in 35 scientific papers and she holds 20 US patents.
She obtained a PhD in Biochemistry- Molecular Biology (Katholieke Universiteit Leuven) and a Certificate in Dermato-Cosmetic Science (Vrije Universiteit Brussel). Based in Belgium and a native speaker of Dutch, she is fluent in English and French, with basic knowledge of German and Italian.
Lieve Declerq, PhD
Rolf has a background within Biomedicine, and received his PhD in Experimental Infection Medicine from Lund University, Sweden. Rolf started his career 2007 working on the skin bacterium Propionibacterium acnes and bacteriophages infecting this bacterium. This research path has continuously been a major part of the research conducted in the Lood lab. Rolf is focusing his research within the field of Experimental Infection Medicine, with an emphasize on a) understanding the beneficial (molecular) role of the skin microbiota, b) elucidating molecular mechanisms behind spread of antibiotic resistance through bacteriophages, and c) investigating experimental means to combat infections. During the last years, a specific focus has been on the P. acnes secreted benevolence factor RoxP identified and characterized by our lab – a potent antioxidant able to protect human skin from oxidative damage.
Besides his academic position, Rolf is the CSO of the biotechnology company Genovis AB, developing enzymes for the study of immunoglobulins.
Rolf Lood, PhD
As an ICREA Research Professor Toni Gabaldon focuses on comparative genomics and phylogenomics to study the origin, evolution and function of complex biological systems.
He has more than 160 scientific publications in the areas of genomics, microbiology and bioinformatics.
Prof. Toni Gabaldon
Prof. Luis Serrano was previously the head of the Structural & Computational Biology Program at the European Molecular Biology Institute (EMBL) in Heidelberg. Since 2011, he has been the director of the Center for Genomic Regulation (CRG).
His group is at the forefront of systems and synthetic biology in Europe. He has authored more than 270 scientific publications and 20 patents.
Prof. Luis Serrano
S-Biomedic is a member of…
-
Start it @kbc supports and promotes innovative and scalable entrepreneurship. With over 477 startups, is Belgium's largest startup community.
-
flanders.bio is a cluster organisation with currently more than 330 members from Belgium and abroad empowering a life sciences driven network economy.
-
The PRI is a European non-profit organization (French Association, 1901), focused on regulatory affairs in the microbiome field for the EU Market.